Stock 4554 FUJI PHARMA CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Fuji Pharma Co., Ltd.

Equities

4554

JP3816200004

Delayed Japan Exchange
Other stock markets
 02:08:02 16/05/2024 BST 		5-day change 1st Jan Change
1,504 JPY -1.64% Intraday chart for Fuji Pharma Co., Ltd. -3.65% -13.40%
2023 Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump MT
2023 Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Bel20 sluit voor de vijfde keer op rij in het rood
Bel20 kleurt volledig rood
Bel20 zakt verder weg
Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump
Licht positieve start in Brussel
Brussel start afwachtend in aanloop naar drukke cijferweek
Mithra krijgt mijlpaalbetaling van Fuji Pharma
Vistagen Therapeutics, Fuji Pharma Sign Exclusive Negotiation Deal for Japanese Market
Vistagen and Fuji Pharma Co., Ltd. Enter Exclusive Negotiation Agreement for Potential License to Develop and Commercialize Vistagen?s Investigational Menopausal Hot Flash Therapy, PH80 Nasal Spray, in Japan
Lotus Pharmaceutical Co., Ltd. and Fuji Pharma Co., Ltd. Joint Product Receives the Approval for Lenalidomide Capsules,2.5 Mg and 5 Mg from the Japan Pmda
Rode start van augustus voor Bel20
Mithra Receives Milestone Payment from Fuji Pharma; Shares Surge 11%
Mithra ontvangt mijlpaalbetaling
Fuji Pharma Co., Ltd. Reports Earnings Results for the Half Year Ended March 31, 2023
Sector Update: Health Care Stocks Mixed Pre-Bell Friday
Alvotech and Fuji Pharma Expands Partnership Adding A New Biosimilar Candidate
Groen licht voor anticonceptiepil Mithra in Thailand
Fuji Pharma Co., Ltd. Submits Application for Marketing Approval of First Biosimilar Candidate in Japan
MÄRKTE ASIEN/Börsen knicken mit russischer Militäroperation ein
Fuji Pharma Co., Ltd. Provides Financial Guidance for the Fiscal Year Ending September 30, 2022
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4554 Stock
  4. News Fuji Pharma Co., Ltd.
  5. Other languages